JEOL Q1 FY2026: China export controls drag revenue and profit

JEOL's consolidated revenue declined year on year in the first quarter of fiscal 2026, with operating profit, ordinary profit and net income attributable to owners of the parent also falling. The company attributed the decline mainly to delays in export-control renewal procedures for China and to the timing of large semiconductor manufacturing equipment orders. Domestic economic conditions remained moderately recovering, but JEOL said the impact of China export controls and tighter restrictions on resist processing equipment in its industrial equipment business weighed on profit. The company left its full-year forecast unchanged, noting that sales and profit tend to be concentrated in the fourth quarter.

Scientific & Measurement Instruments
Sales fell year on year, despite solid demand for electron microscopes across advanced R&D, semiconductors, materials and life sciences. Delays in export-control renewal procedures for Chinese universities and research institutions weighed on the segment.

Industrial Equipment
Sales also declined. Semiconductor resist coating equipment was affected by the timing of some large orders, while resist developing equipment was hit by tighter export controls on certain regions. Orders for paste coating equipment and electronic component inspection equipment remained firm.

Following the divestiture of the medical equipment business in the previous fiscal year, JEOL now reports two segments: Scientific & Measurement Instruments and Industrial Equipment.

Total assets at the end of the first quarter were lower than at the prior fiscal year-end. Notes and accounts receivable, contract assets, cash and deposits, and deferred tax assets declined, while investment securities and inventories increased. Total liabilities also fell, as short-term borrowings, accounts payable and income taxes payable decreased, although contract liabilities increased. Net assets declined due to a decrease in retained earnings, but the equity ratio rose from the prior year-end. The company made no change to its full-year dividend forecast and said it continues to balance growth investment with shareholder returns under its medium-term capital policy.

• Delays or tightening of export-control renewal procedures for China, causing sales recognition delays
• Timing fluctuations of large semiconductor manufacturing equipment orders
• Macroeconomic and geopolitical risks, including U.S. and European monetary policy and a slowing Chinese economy
• Higher resource and energy prices and inflation driving cost increases
• Quarterly earnings volatility due to concentration of sales and profit in the fourth quarter

China export controls are a particularly important watch point because they directly affect deliveries to universities and research institutions, the main market for the Scientific & Measurement Instruments segment.

JEOL left its fiscal 2026 full-year earnings forecast unchanged from the previous announcement. The company said the timing impact of some large orders and tighter export restrictions were mostly incorporated into its initial plan, and that business progress and orders are tracking within expectations. However, sales and profit tend to be concentrated in the fourth quarter, so full-year results will depend heavily on the second half, particularly the fourth quarter. A revision could become necessary if Chinese export-control procedures stall further or semiconductor market conditions change.